Incyte Reports 2018 Second Quarter Financial Results and Updates on Key Clinical Programs
Go back to Incyte Reports 2018 Second Quarter Financial Results and Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 104.40 +0.74 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.66 | 52 Week High | $118.49 | |||
| Open | $104.61 | 52 Week Low | $55.00 | |||
| Day High | $105.48 | P/E | N/A | |||
| Day Low | $103.07 | EPS | $-0.56 | |||
| Volume | 1,793,418 | |||||
